Infection Control Service recent press Read article Read article Read article Read article PRESS RELEASE Casey-Drew Williams 3/6/23 PRESS RELEASE Casey-Drew Williams 3/6/23 Next Gen Diagnostics CEO Paul Rhodes Announces Formation of UK Subsidiary, Next Gen Diagnostics UK, Ltd. Read More PRESS RELEASE Casey-Drew Williams 2/8/23 PRESS RELEASE Casey-Drew Williams 2/8/23 NGD CEO Paul Rhodes Announces Publication in the Journal of Clinical Microbiology Validating Machine Learning-Based Resistance Prediction Read More PRESS RELEASE Casey-Drew Williams 2/7/23 PRESS RELEASE Casey-Drew Williams 2/7/23 NGD CEO Paul Rhodes Announces Appointment of Brigitte Frankel to its Advisory Board Read More PRESS RELEASE Casey-Drew Williams 1/9/23 PRESS RELEASE Casey-Drew Williams 1/9/23 Next Gen Diagnostics CEO Paul A. Rhodes Announces Formation of Subsidiary NGD Israel, Ltd. Read More PRESS RELEASE Casey-Drew Williams 9/22/22 PRESS RELEASE Casey-Drew Williams 9/22/22 Next Gen Diagnostics Announces Vanderbilt Professor and Leader in Antibiotic Susceptibility Testing Dr. Romney Humphries Has Joined Next Gen Diagnostics Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 9/19/22 PRESS RELEASE Casey-Drew Williams 9/19/22 Next Gen Diagnostics announces Cleveland Clinic Microbiology Laboratory Medical Director Dr. Daniel Rhoads has joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 3/26/20 PRESS RELEASE Casey-Drew Williams 3/26/20 Next Gen Diagnostics Announces that MIT Associate Professor and Broad Institute Core Faculty member Paul Blainey has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 3/3/20 PRESS RELEASE Casey-Drew Williams 3/3/20 Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing Read More PRESS RELEASE Casey-Drew Williams 7/11/18 PRESS RELEASE Casey-Drew Williams 7/11/18 Next Gen Diagnostics Announces that Dr. Tony Cox, Director of Advanced Sequencing Pipeline Research at the Wellcome Sanger Institute, Has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 1/10/18 PRESS RELEASE Casey-Drew Williams 1/10/18 Next Gen Diagnostics Selected to Partner with a UK Consortium To Conduct The First Trial Of Prospective Sequencing-Enabled Transmission Detection, At Addenbrooke’s Hospital, In Cambridge, UK. Read More PRESS RELEASE Casey-Drew Williams 11/1/17 PRESS RELEASE Casey-Drew Williams 11/1/17 Next Gen Diagnostics Announces that Professor Sharon Peacock, of the London School of Hygiene and Tropical Medicine, Has Joined its Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 8/19/17 PRESS RELEASE Casey-Drew Williams 8/19/17 Next Gen Diagnostics Announces that Professor Julian Parkhill, Pathogen Genomics Group Leader at the Sanger Institute, Has Joined its Scientific Advisory Board Read More Newer Posts Older Posts
PRESS RELEASE Casey-Drew Williams 3/6/23 PRESS RELEASE Casey-Drew Williams 3/6/23 Next Gen Diagnostics CEO Paul Rhodes Announces Formation of UK Subsidiary, Next Gen Diagnostics UK, Ltd. Read More
PRESS RELEASE Casey-Drew Williams 2/8/23 PRESS RELEASE Casey-Drew Williams 2/8/23 NGD CEO Paul Rhodes Announces Publication in the Journal of Clinical Microbiology Validating Machine Learning-Based Resistance Prediction Read More
PRESS RELEASE Casey-Drew Williams 2/7/23 PRESS RELEASE Casey-Drew Williams 2/7/23 NGD CEO Paul Rhodes Announces Appointment of Brigitte Frankel to its Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 1/9/23 PRESS RELEASE Casey-Drew Williams 1/9/23 Next Gen Diagnostics CEO Paul A. Rhodes Announces Formation of Subsidiary NGD Israel, Ltd. Read More
PRESS RELEASE Casey-Drew Williams 9/22/22 PRESS RELEASE Casey-Drew Williams 9/22/22 Next Gen Diagnostics Announces Vanderbilt Professor and Leader in Antibiotic Susceptibility Testing Dr. Romney Humphries Has Joined Next Gen Diagnostics Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 9/19/22 PRESS RELEASE Casey-Drew Williams 9/19/22 Next Gen Diagnostics announces Cleveland Clinic Microbiology Laboratory Medical Director Dr. Daniel Rhoads has joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 3/26/20 PRESS RELEASE Casey-Drew Williams 3/26/20 Next Gen Diagnostics Announces that MIT Associate Professor and Broad Institute Core Faculty member Paul Blainey has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 3/3/20 PRESS RELEASE Casey-Drew Williams 3/3/20 Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing Read More
PRESS RELEASE Casey-Drew Williams 7/11/18 PRESS RELEASE Casey-Drew Williams 7/11/18 Next Gen Diagnostics Announces that Dr. Tony Cox, Director of Advanced Sequencing Pipeline Research at the Wellcome Sanger Institute, Has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 1/10/18 PRESS RELEASE Casey-Drew Williams 1/10/18 Next Gen Diagnostics Selected to Partner with a UK Consortium To Conduct The First Trial Of Prospective Sequencing-Enabled Transmission Detection, At Addenbrooke’s Hospital, In Cambridge, UK. Read More
PRESS RELEASE Casey-Drew Williams 11/1/17 PRESS RELEASE Casey-Drew Williams 11/1/17 Next Gen Diagnostics Announces that Professor Sharon Peacock, of the London School of Hygiene and Tropical Medicine, Has Joined its Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 8/19/17 PRESS RELEASE Casey-Drew Williams 8/19/17 Next Gen Diagnostics Announces that Professor Julian Parkhill, Pathogen Genomics Group Leader at the Sanger Institute, Has Joined its Scientific Advisory Board Read More
